St. Jude Children’s Research Hospital ENSEMBLE Trial Volunteers Receiving Placebo Might Access J&J Vaccine First
With the recent Emergency Use Authorization (EUA) of the Johnson & Johnson vaccine, who will first receive the vaccine when […]
Broad Institute & UBC Researchers Develop COVID-19 Tracking Tool to Help Identify Mutations by Geography
A research team from the Broad institute, the University of British Columbia and 4Fusion Genomics Corporation have developed an open, free public browser […]
By End of Feb, 7% of Americans have Received Full 2-Dose Vaccination Against COVID-19
By the end of February, 7% of the American population had been fully vaccinated with either one of the two […]
International Clinical Trial ‘REMAP-CAP’ Includes Ivermectin Among Study Drugs for COVID-19 Treatment
The global clinical trial, (REMAP-CAP (NCT02735707), is supported by multiple international funding organizations, including the Canadian Institutes of Health Research, the […]
News Roundup | Johnson & Johnson Single-Dose Vaccine Authorized for Emergency Use
Article 1 Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study: Johnson […]
University of Washington-Led Study Reveals Single SARS-CoV-2 Mutation Triggers COVID-19 Variant Expansion & Greater Public Health Concern
A recent study led by University of Washington and involving other agencies and organizations, from the Antibiotic Resistance Monitoring Analysis […]
NIAID to Launch Major Clinical Trial Investigating Severe Allergic Reactions with COVID-19 Vaccines from Moderna & Pfizer/BioNTech
As TrialSite has monitored allergic vaccine reactions associated with mRNA-based COVID-19 vaccines under U.S. Food and Drug Administration (FDA) emergency […]
Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study
Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency […]
Research Shows MMR Vaccine May Protect Against Severe COVID-19 Outcomes
During the 2020 measles outbreak in February, Dr. Desiree E.S. Larenas Linnemann, MD, FAAAAI, Médica Sur Clinical Foundation, led a […]
China’s Ad5-nCoV COVID-19 Vaccine Granted Conditional Marketing Authorization
This week, the China National Medical Products Administration (NMPA) granted conditional marketing authorization of Recombinant COVID-19 Vaccine (Adenovirus Type 5 […]
